Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Clinical features and outcomes of myeloproliferative neoplasm patients with MPL mutations and concurrent JAK2/calr mutations

View Full Paper
Ask AI
Bookmark
Share

Authors

SGSwapnil GajjarAKAndrew Kuykendall

Discussion

Loading...

Member takes

Overview

Case series reveals clinical features of myelofibrosis patients with dual MPL and CALR mutations, suggesting unique prognostic implications.

Key Points

  • Concurrent MPL and CALR mutations were documented in myelofibrosis patients, indicating a potential connection between genetic drivers.
  • From 87 patients with MPL mutations, 11 demonstrated dual mutations, suggesting a higher frequency of co-occurrence than previously thought.
  • Retrospective case series analyzed clinical data from two cancer centers, focusing on patient demographics and treatment outcomes.
  • Further research is essential to determine the therapeutic implications of unique MPL and CALR mutations in diverse cohorts.

Cite This Study

Gajjar et al. (2025) studied this question.

synapsesocial.com/papers/69362f6e4fa91c937236e07ahttps://doi.org/10.1182/blood-2025-7354
View Full Paper
Ask AI
Bookmark
Share